Literature DB >> 21644038

Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation.

Hidefumi Ito1, Masataka Nakamura, Osamu Komure, Takashi Ayaki, Reika Wate, Hirofumi Maruyama, Yoshimi Nakamura, Kengo Fujita, Satoshi Kaneko, Yoko Okamoto, Masafumi Ihara, Tetsuro Konishi, Kazumasa Ogasawara, Asao Hirano, Hirofumi Kusaka, Ryuji Kaji, Ryosuke Takahashi, Hideshi Kawakami.   

Abstract

We investigated a family manifesting amyotrophic lateral sclerosis (ALS) with a heterozygous E478G mutation in the optineurin (OPTN) gene. Clinically, slow deterioration of motor function, mood and personality changes, temporal lobe atrophy on neuroimaging, and bizarre finger deformity were noted. Neuropathologically, TAR DNA-binding protein 43 (TDP-43)-positive neuronal intracytoplasmic inclusions were observed in the spinal and medullary motor neurons. In these cells, the immunoreactivity of nuclear TDP-43 was reduced. Consecutive sections revealed that the inclusions were also reactive with anti-ubiquitin and anti-p62 antibodies, but noticeably negative for OPTN. In addition, TDP-43/p62-positive glial cytoplasmic inclusions (GCIs) were scattered throughout the spinal cord and the medullary motor nuclei. Furthermore, Golgi fragmentation was identified in 70% of the anterior horn cells (AHCs). The presence of AHCs with preserved nuclear TDP-43 and a fragmented Golgi apparatus, which are unrecognizable in sporadic ALS, indicates that patients with the E4787G OPTN mutation would manifest Golgi fragmentation before loss of nuclear TDP-43. In the neocortex, GCIs were sparsely scattered among the primary motor and temporal cortices, but no neuronal TDP-43-positive inclusions were detected. In the amygdala and the ambient gyrus, argyrophilic grains and ballooned neurons were seen. The thorough neuropathologic investigations performed in this work demonstrated that OPTN-positive inclusion bodies, if any, were not prominent. We postulate that optineurinopathy is closely linked with TDP-proteinopathy and speculate that this heterozygous E478G mutation would cause ALS by acting through a dominant-negative mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644038     DOI: 10.1007/s00401-011-0842-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation.

Authors:  Maria Martinez-Lage; Laura Molina-Porcel; Dana Falcone; Leo McCluskey; Virginia M-Y Lee; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-08       Impact factor: 17.088

2.  Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.

Authors:  Andrew S Moore; Erika L F Holzbaur
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

3.  Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein.

Authors:  Megha Bansal; Shivranjani C Moharir; S Purnima Sailasree; Kapil Sirohi; Cherukuri Sudhakar; D Partha Sarathi; B Jyothi Lakshmi; Mario Buono; Satish Kumar; Ghanshyam Swarup
Journal:  J Biol Chem       Date:  2017-11-13       Impact factor: 5.157

Review 4.  From animal models to human disease: a genetic approach for personalized medicine in ALS.

Authors:  Vincent Picher-Martel; Paul N Valdmanis; Peter V Gould; Jean-Pierre Julien; Nicolas Dupré
Journal:  Acta Neuropathol Commun       Date:  2016-07-11       Impact factor: 7.801

Review 5.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 6.  The frontotemporal syndromes of ALS. Clinicopathological correlates.

Authors:  Michael Joseph Strong; Wencheng Yang
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

Review 7.  Neurodegenerative diseases: model organisms, pathology and autophagy.

Authors:  S N Suresh; Vijaya Verma; Shruthi Sateesh; James P Clement; Ravi Manjithaya
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.

Authors:  Wen-Chuan Shen; Huei-Ying Li; Guang-Chao Chen; Yijuang Chern; Pang-Hsien Tu
Journal:  Autophagy       Date:  2015-04-03       Impact factor: 16.016

Review 9.  The role of autophagy in neurodegenerative disease.

Authors:  Ralph A Nixon
Journal:  Nat Med       Date:  2013-08-06       Impact factor: 53.440

10.  Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells.

Authors:  Ivana Munitic; Maria Letizia Giardino Torchia; Netra Pal Meena; Guozhi Zhu; Caiyi C Li; Jonathan D Ashwell
Journal:  J Immunol       Date:  2013-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.